TIA triage in Not all that glitters is gold

Similar documents
TIA: Updates and Management 2008

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

Critical Review Form Therapy

Management and Investigation of Ischemic Stroke By Etiology

Cryptogenic Strokes: Evaluation and Management

Emergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan

TRANSIENT ISCHEMIC ATTACK (TIA)

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Therapy for Acute Stroke. Systems of Care for TIA

David Strain, Diabetes and Vascular Research Centre University of Exeter Medical School, UK

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

How do we assess risk in TIA?

2015 Update in Diagnosis and Management of Stroke

2018 Update in Diagnosis and Management of Stroke

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

PFO Management update

Secondary Stroke Prevention

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

TIA. What it is, What it isn t, What to do about it, and When WM. BLAINE BENDURE, MD, MS BOARD CERTIFIED NEUROLOGIST

The DAWN of a New Era for Wake-up Stroke

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE OR TIA December 8, 2017

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Document Title: The Management of Acute Ischemic Stroke & TIA

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Alan Barber. Professor of Clinical Neurology University of Auckland

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Speakers. 2015, American Heart Association 1

Secondary Stroke Prevention: A Precautionary Tale

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland

2/7/

Intracranial Atherosclerosis in Asians

Can ABCD 2 score predict the need for in-hospital intervention in patients with transient ischemic attacks?

2014 Update in Diagnosis and Management of Stroke

The annual incidence of TIA in the United States is

STROKE UPDATE ANTHEA PARRY MAY 2010


Does ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack?

Stroke/TIA. Tom Bedwell

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

Permanent foramen ovale: when to close?

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

44TH ANNUAL RECENT ADVANCES IN NEUROLOGY

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Early Hospitalization of Patients with TIA: A Prospective, Population-based Study

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

Department Specific Guideline

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

Significant Relationships

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Oltre la terapia medica nelle dissezioni carotidee

Stroke: What did we learn in the last year?

Interventional Treatment of Stroke

ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine

Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia

Carotid Artery Stenting

2018 Early Management of Acute Ischemic Stroke Guidelines Update

GOVERNANCE BOARD. 14th January Clinical Audit of Stroke Services. At Shrewsbury and Telford Hospitals NHS Trust

Supplementary Online Content

Management of TIA. Dr Ali Ali Consultant Stroke and Geriatrics Royal Hallamshire Hospital

Reducing delays to outpatient assessment of strokes and TIAs

OHSU HEALTH CARE SYSTEM PRACTICE GUIDELINES

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician

Recent Advances in Neurology Difficult Cases

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

Practical Considerations in the Early Treatment of Acute Stroke

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute

Comparison of Five Major Recent Endovascular Treatment Trials

The Importance of Stroke Programs in an Acute Care Setting by Debbie Estes, RN, BSN Stroke Program Coordinator, Medical City of Dallas

Cryptogenic Stroke: A logical approach to a common clinical problem

It is the nature of a stroke to partly take away the use of a man s limbs and to throw him onto the parish if he had no children to look to

OHSU Health Care System

Endovascular Neurointervention in Cerebral Ischemia

Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015

A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects

Alma Mater Studiorum Università di Bologna

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1)

Retrospective Study on the Safety and Efficacy of Clopidogrel in the Treatment of Acute Cerebral Infarction

Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology

Emergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)

Chinook Regional Hospital Stroke Alert Cases

Supplementary Online Content

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development

Michael Horowitz, MD Pittsburgh, PA

Endovascular Treatment for Acute Ischemic Stroke: Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington

AMSER Case of the Month: March 2019

Transcription:

TIA triage in 2016 Not all that glitters is gold

Disclosures No industry related disclosures Expert witness work

Overview Definition Implications Guidelines, secondary prevention Implementation of guidelines

Definition A TIA is a sudden neurological deficit, caused by a vascular problem, that completely resolves.

Definition A TIA is a sudden neurological deficit, caused by a vascular problem, that completely resolves. Key features 1 Sudden, as opposed to rapid Absence of nonspecifc symptoms

TIA A TIA is a sudden neurological deficit, caused by a vascular problem, that completely resolves. 20 min to 3 hrs There may or may not be evidence of infarction on MRI/DWI

Case 1 82yoM with Atrial Fibrillation (INR 1.6) and old right frontal lobe ischemic stroke. P/W sudden speech problems, 19:45, totally resolved by 21:00 in the ED NIHSS=0 in the ED HCT unremarkable (except old infarct) HB12272002

TIA: short term risk of stroke Study (year) 2 days 7 days 30 days Johnston (2000) 5% Lovett (2003) 9% 12% Gladstone (2004) 8% Coull (2004) 8% 12% Kleindorfer (2004) 4% 7% 11% Correia (2006) 13% Average 4.5% 8.5% 11%

TIA: short term risk of stroke Study (year) 2 days 7 days 30 days Johnston (2000) 5% Lovett (2003) 9% 12% Gladstone (2004) 8% Coull (2004) 8% 12% Kleindorfer (2004) 4% 7% 11% Correia (2006) 13% Average 4.5% 8.5% 11%

ABCD 2 score 2 Factor, points OR (95% CI) Age ( 60yrs = 1 point) 1.4 (1.0-2.1) BP ( 140 mmhg systolic or 90 diastolic 1 point) 1.6 (1.1-2.2) Clinical Features:.Unilateral weakness 2 points.speech impairment without weakness 1 point Duration: 60 minutes 2 points 10-59 minutes 1 point 2.9 (2.0-4.3) 1.4 (0.8-2.3) 2.3 (1.3-4.0) 2.0 (1.0-3.7) Diabetes (Presence 1 point) 1.6 (1.1-2.2)

Risk stratification with ABCD 2 score 2 Days stroke Risk after TIA ABCD2 Score 25% 20% 15% 10% 5% 0% 0% 0% Low risk Moderate risk 1% 1% 4% 5% High risk 8% 6% 2 Day 0 1 2 3 4 5 6 7 Stroke Risk

Risk stratification with ABCD 2 score Stroke Risk 25% 20% 15% 10% 5% 0% 2 day and 90 day stroke risk after TIA High risk Low risk 0% 2% 3% 3% Moderate risk 8% 12% 17% 22% 2 Day 90 Day 0 1 2 3 4 5 6 7 ABCD2 score 4799 patients

Case 1 Who are the 0-8% of patients with TIA, who develop stroke in the fist 2 days?

Case 1 The patient s ABCD 2 score =4 2-day risk of stroke is 4% 90-day risk of stroke is 8% The mechanism of the TIA is probably known a-fib, while sub-therapeutic on warfarin

Case 1 We know the cause We have the treatment Our management options: A) Obtain immediate vascular imaging in ED B) Admit to hospital, observation, workup, anticoagulation C) Discharge home with bridge anticoagulation D) Discharge to home without bridge, but augment warfarin dose and recheck INR in 48hrs

Case 1 82yoM with Atrial Fibrillation (INR 1.6) and old right frontal lobe ischemic stroke. P/W sudden slurred speech, 19:45, totally resolved by 21:00 in the ED NIHSS=0 in the ED HCT unremarkable (except old infarct) Cr = 1.5, CTA deferred, pt admitted for MRA HB12272002

Case 1 Admitted, MRA pending Discovered in room, aphasic, right hemiparetic NIHSS = 22 HB12272002

HB12272002

Case 1 Despite successful technical revascularization of a left M2 occlusion, the patient s deficits did not improve. Based on prior medical problems, was already dependent (mrs 2), the family withdrew care and the patient expired. HB12272002

Case 1 Despite successful technical revascularization, of a left M2 occlusion, the patient s deficits did not improve. Based on prior medical problems, was already dependent (mrs 2), the family withdrew care and the patient expired. The patient went from no deficit to death. HB12272002

Case 1 The left M2 occlusion caused the large stroke

Case 1 The left M2 occlusion caused the large stroke Was the left M2 occlusion present initially when his NIHSS resolved to 0?

Case 1 The left M2 occlusion caused the large stroke Was the left M2 occlusion present initially when his NIHSS resolved to 0? The ABCD score predicted low risk of stroke, so why did this happen?

Case 1 The left M2 occlusion caused the large stroke Was the left M2 occlusion present initially when his NIHSS resolved to 0? The ABCD score predicted low risk of stroke, so why did this happen? Is the ABCD score a tool we can use to triage the TIA patient?

Case 1 The left M2 occlusion caused the large stroke Was the left M2 occlusion present initially when his NIHSS resolved to 0? The ABCD score predicted low risk of stroke, so why did this happen? Is the ABCD score a tool we can use to triage the TIA patient? What is the cause of stroke following TIA?

What causes TIA in general?

What causes TIA in general? Cardioembolism Atrial fibrillation Cardiomyopathy Paradoxical Septic Atherothrombo/embolism Arch Extrancranial ICA, VA COW: MCA, iica, BA Dissection ICA, VA Lacunar lipohyalinosis Small vessel Cerebral Venous Thrombosis

Hypothesis One feature that characterized Case 1 is the presence of large vessel occlusion (LVO)

Hypothesis One feature that characterized Case 1 is the presence of large vessel occlusion (LVO) Hypothesis: LVO is associated with increased risk of stroke following TIA, regardless of ABCD 2 score.

Coutts et al (2008) 3 Prospective cohort study 180 pts with TIA or minor stroke (NIHSS 0-3), followed for 90 days Intracranial Vessel Occlusion n=24 (13%) In the 24 with LVO, 46% had symptomatic clinical progression Compared with 6% without LVO, RR 7.9 (3.7-17.1) Presence of LVO raised the risk of stroke 8-fold University of Calgary

Coutts et al (2009) 4 Retrospective cohort, mild AIS or TIA, 2002-07 Had CT + CTA i/e 297 pts identified, 90 day follow up Outcome poor mrs 2 at 90d or d/c to other than home (rehab or nursing home) CTA: presence or absence of large vessel occlusion or severe (>50%) stenosis in either the circle of Willis (COW) or extracranial circulation

Coutts et al (2009) 4 In the poor outcome category, 27/57 (48%) had an LVO/SS COW + LVO/SS in 17/57(30%) of poor outcome vs 45/400(11%) of good outcome, p=0.0006 Extracran + LVO/SS in 10/57 (18%) of poor outcome vs 35/400 (9%) of good outcome, p=0.054 The presence of LVO/SS is correlates with a poor outcome, especially if the lesion is in the Circle of Willis.

Smith et al (2009) STOPStroke 5, prospective cohort Stroke/TIA and CT/A 33 months, 735 enrolled, n=97 TIA Of the TIA cases, 13 (13%) had LVO Overall, +LVO associated with 4.5-fold increased odds of death (95%CI 2.7-7.3, p<0.001) and absent LVO +3.2-fold increased odds of good outcome (95% CI 2.2-4.2, p<0.001) They did not have enough TIA cases to study TIA specifically UCSF-MGH, Screening Technology and Outcome Project in Stroke Study

Predictors of risk of early stroke Higher ABCD 2 score Presence of LVO/SS

Predictors of risk of early stroke Higher ABCD 2 score Presence of LVO/SS But, does high ABCD 2 = LVO?

Predictors of risk of early stroke Higher ABCD 2 score Presence of LVO/SS But, does high ABCD 2 = LVO? There is little data Arterial dissection First presentation of atherosclerotic disease

Management Guidelines 7 Class 1 Evidence Patients with TIA should preferably undergo neuroimaging evaluation within 24 hours of symptom onset. Noninvasive imaging of the cervicocephalic vessels should be performed. Patients with suspected TIA should be evaluated as soon as possible.

Management Guidelines 7 ECG should occur as soon as possible; prolonged cardiac monitoring is useful in patients with an unclear Echocardiography (at least TTE) is reasonable, especially in patients in whom no cause has been identified by other elements of the

Prevention Guidelines 8 Antiplatelet medication BP control HMG CoA reductase inhibitors Revascularization for symptomatic carotid stenosis Anticoagulation for afib

What s lacking Hospitalization Admit, observation, or discharge Selection Testing Urgency of vascular imaging Urgency of echo, rhythm analysis, blood work Ranta and Barber (2016) 9 University of Otago, Auckland University, NZ

Model 1 Admit all TIA cases to hospital or ED observation unit, with input from a stroke specialist. Pro: expert-driven, ability to observe and treat in case of worsening Con: clinical benefit unproven; no cost benefit

Model 2 Sanders et al (2012) 10 ED assessment Persistent signs, crescendo TIA, other medical issues: admission Otherwise TIA clinic same or next day Vascular imaging: same or next day CDUS Afib: anticoagulation, priority for TIA clinic No afib, +CDUS ICAS>50%: CTA and priority to TIA clinic Monash University, Australia

Model 2 468 patients with 90 day follow up 150 control admission method Outcome = stroke at 90 days Stroke 1.50% (7/468) in Model 2, vs 4.67% (7/150) in admission method

Model 3 SOS-TIA, Lavallee et al (2007) 11 Specialized 24/7 clinic Not clear who saw the pts, but 24/7 vascular neurologist available at least by phone CDUS, TCD and ECG If high suspicion, then urgent TTE Direct communication bw VN and PCP re secondary prevention strategy Discharge to home The Paris model, Bichat-Claude Bernard University

Model 3 643 pts had definite TIA Overall 1.24% (0.72-2.12) risk of stroke at 90 days, compared with estimated 5.96% based on ABCD 2 scores for this cohort

Model 4 Rothwell et al (2007) 12, EXPRESS study Compared routine TIA outpatient referral (med 3 days, CDUS, TTE, no immediate initiation of meds) to same-day open-access clinic (M-F) with immediate initiation of meds. Reduction of 90-day stroke from 10.3% to 2.1%, HR 0.2., 0.08-0.49, p = 0.0001) The Oxford model,

Model 5 Olivot (2011) 13 TWO ACES stud Prospective study, 224 pts that came to ED ABCD 2 = 0-3: sent from ED to TIA clinic (<48hr), MRA i/e or CTA i/e between ED and TIA clinic ABCD 2 = 4-5: CTA i/e CTA i/e lesion >50% stenosis, admission Otherwise, TIA clinic The Stanford model

Model 5 Pts referred to TIA clinic had a stroke rate of 0.6% at 7 days (same at 90 d!), compared with expected 4.0, 7.1 % risk based on ABCD 2 score, p<0.034, p<0.001

Model 6 Wasserman et al (2010) 14 ED visit, dx of TIA Outpt CDUS, TTE, FLP ABCD 2 6: 7 day f/u in TIA clinic ABCD 2 = 3-5: 14 day f/u in TIA clinic ABCD 2 < 4: >14 day f/u The Ottawa model

Model 6 >1000 pts, outcome stroke at 90 days ABCD2 score Strokes Predicted P <4 (n=321) 3, 0.9% (0-1.98) 3.1 0.0364 4-5 (n=469) 18, 3.8% (2.1-5.58) 9.8 <0.0001 6 (n=192) 10, 5.2% (2.07-8.35) 17.8 <0.0001 Combined 31, 3.2% (2.07-4.25) 9.1 <0.0001

Model 7 Ranta et al (2015)15 PCP with web-based decision tool triage to TIA clinic vs usual care by PCP Web based tool High risk ABCD2>3, 2 or more recent events, presence of afib referral to TIA clinic 24 hrs Low risk TIA clinic within 7 days

Model 7 90-day stroke outcomes Intervention, 2/172 (1.2%) Control, 5/119 (4.2%) P = 0.098

Comparison Model Pro Con 1 -Full and immediate vascular imaging -Ability to intervene if patient worsens 2-7 -Avoids most hospitalization, cost savings -Unproven clinical benefit, higher cost -There is clinical benefit when compared with the ABCD 2 risk, ie compared with doing nothing.

What is the goal? Cost savings? Reduction of stroke risk?

Hypothetical goals Reduction of cost, hospitalization Elimination (not reduction) of risk of stroke This must include imaging of all cervicocranial vessels, knowing what we know about LVO and its strong correlation with poor outcome.

The UPMC-Mercy Model Brain and vascular imaging in ED MRI brain, MRA head and neck If no infarct, and no LVO/SS, then observe 24h: ABCD 2 >3, observe inpatient, complete workup ABCD 2 <3, observe in clinical decision unit in the ED, then discharge home

Beyond Mercy If there is no afib and no LVO/SS, then Antiplatelet Address BP, glucose, LDL Discharge home Outpatient Holter Follow up in Stroke clinic, next business day

1. Cerebrovasc Dis 2008;26: 630-635 2. Lancet 2007; 369:283-292 3. Stroke 2008; 39: 2461-2466 4. Intnl. J. Stroke, 2009; 4: 448-453 5. Stroke 2009; 40: 3834-3840 6. Neurohospitalist 2011; 1(4): 187-199 7. Stroke 2009; 40: 2276-2293 8. Stroke 2014; 45: 2160-2236 9. Neurology 2016; 86: 947-953 10. Stroke 2012; 43: 2936-2941 11.Lancet Neurology 2007; 6:953-60 12. Lancet 2007;370:1432-42 13. Stroke 2011; 42:1839-1843 14. Stroke 2010; 41:2601-2605 15. Neurology 2015;84:1545-1551 References